Drug Companies making Epilepsy medication MRNS $10.08 CERE $43.16 STOK $4.98 UCBJF $102.00 SNY $45.63 PFE $27.00 OTSUK $18.36 RespireRx Pharmaceuticals Ticker: RSPI .0012 x .0014
Market cap $613,263 Is working on Revolutionary New Hope: KRM-II-81 Drug-Resistant Epilepsy Patients
Link found on National Library of Medicine The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders
National Institutes of Health A clinical case of a 19-year-old male patient with pharmacoresistant seizures occurring following parieto-occipital tumor-resection at age 6 ... KRM–II–81 suppresses epileptifom activity across the neural network of cortical tissue from a patient with pharmacoresistant epilepsy https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10784158/
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.